Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Texas EnteroSorbents has developed proprietary clay-based enterosorbent products that bind a wide range of toxins including mycotoxins in food/feed and persistent organic pollutants in the environment. Their products have demonstrated efficacy in laboratory studies as well as double-blind placebo trials to reduce toxin uptake in humans. Some products are commercially available for animal health; others are being tested or deployed for broader environmental or emergency response uses[1][2][5][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Texas EnteroSorbents.